Skip Navigation

Corrigendum for de Martimprey et al., Nucl. Acids Res. 36 (1) e2.
Nucleic Acids Research 2008 36(21):6944; doi:10.1093/nar/gkn882
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (157K) Freely available
Right arrow Screen PDF (224K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by de Martimprey, H.
Right arrow Articles by Malvy, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by de Martimprey, H.
Right arrow Articles by Malvy, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2008, Vol. 36, No. 21 6944
© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corrigendum

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma

Henri de Martimprey, Jean-Remi Bertrand, Alfredo Fusco, Massimo Santoro, Patrick Couvreur, Christine Vauthier and Claude Malvy

The first 10% of the full text of this article appears below.

Nucleic Acids Res. (2008) 36, e2

The authors . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?